Short-term Psychological Outcomes of Disclosing Amyloid Imaging Results to Research Participants Who Do Not Have Cognitive Impairment
Joshua D. Grill(University of California, Irvine), Jason Karlawish(University of Pennsylvania), Michael Donohue(Alzheimer’s Disease Neuroimaging Initiative), Paul Aisen(University of California, San Diego), David L. Sultzer(University of California, Irvine), Jeffrey M. Burns(Alzheimer’s Disease Neuroimaging Initiative), Rema Raman(University of Southern California), Karin Ernström(University of Southern California), Reisa A. Sperling(Harvard University), Keith A. Johnson(Brigham and Women's Hospital)
Cited by 94
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
|Alzheimer s & Dementia|2014|3.1k